Evaluation of COPD progression based on spirometry and exercise capacity.

Area of Science:

• Pulmonary Medicine
• Cardiorespiratory Physiology
• Clinical Exercise Physiology

Background:

• Chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow limitation.
• COPD progression, particularly the annual decline in forced expiratory volume in one second (FEV1), is highly variable.
• Reduced exercise capacity is common in COPD patients and worsens over time.

Purpose of the Study:

• To investigate the long-term changes in FEV1 and exercise capacity in COPD patients.
• To determine the relationship between the decline in FEV1 and exercise capacity over a 10-year period.

Main Methods:

• A longitudinal study involving 22 male COPD patients over 10 years.
• Annual pulmonary function testing, including FEV1 measurements.
• Baseline and 10-year exercise testing using a cycle ergometer to assess maximal oxygen uptake (VO2max) and ventilation.

Main Results:

• Significant declines in FEV1, VO2max, maximal work, and ventilation were observed over the 10-year period.
• Annual FEV1 decline averaged 42 mL; VO2max declined by 30 mL/min/yr.
• Changes in FEV1 did not predict changes in VO2max, but changes in maximal minute ventilation correlated with VO2max changes.

Conclusions:

• Exercise capacity deteriorates in COPD patients over time, independently of airflow limitation.
• Baseline FEV1 predicts the annual rate of FEV1 decline.
• Long-term monitoring of exercise capacity is essential for comprehensive COPD management alongside pulmonary function tests.